Atlanta, Georgia-based United Musculoskeletal Partners (UMP) has merged with Dallas, Texas-based Novum Orthopedic Partners, an orthopedic practice management company creating a network of 320 orthopedic care providers across several states.
Merger Creates New, 320 Ortho Provider Network
1 min read Premium comments
Secondary#unitedmusculoskeletalpartners#novumorthopedicpartners
Included in this announcement was the news that UMP is also adding Denver, Colorado-based Panorama Orthopedics as a founding practice. Panorama joins founding partners Atlanta, Georgia-based Resurgens Orthopaedics and Dallas, Texas-based Arlington Orthopedic Associates.
Resurgens Orthopaedics, Georgia’s largest orthopedic practice, together with New York, New York-based Welsh, Carson, Anderson & Stowe, a private equity firm, created UMP in December 2021. With the addition of Novum and Panorama, UMP will have a presence in Colorado, Georgia, and Texas that includes almost 190 physician partners and 320 providers.
UMP is a physician-owned management services company that focuses on musculoskeletal care. The company’s goal is to “partner with entrepreneurial, physician-owned orthopedic practices to deliver exceptional clinical care to patients around the country while simplifying the management functions of the practices under one umbrella company.”
UMP CEO Alex Bateman said, “This merger will allow UMP to continue adding like-minded practices to our footprint, as we build the leading musculoskeletal enterprise in the nation.”
In December 2021, Novum created a new Texas-based orthopedic practice management platform, investing in Arlington Orthopedic Associates; Abilene Sports Medicine & Orthopedics; Waxahachie Orthopedic and Sports Medicine; Abilene Center of Orthopedics and Multispecialty Surgery; and Baylor Scott & White Orthopedic Spine Hospital at Arlington.
For OTW’s coverage of Novum’s investments, see “Novum Orthopedic Partners Invests in Five Texas Practices.”
Novum Chief Development Officer Eric Slimmer commented, “The timing was serendipitous that we could merge these two newly formed ventures into one, high-performing platform.”
Slimmer continued, “Our visions are aligned and that favorably positions us to execute on our goals together.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.